Table 3 Outcomes by disease at baseline and differences with the outcomes in the follow-up
CVR | COPD | DMII | Total sample | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Mean at baseline (sd) | Mean change (sd) | Range of change across DMPs # | Mean at baseline (sd) | Mean change (sd) | Range of change across DMPs # | Mean at baseline (sd) | Mean change (sd) | Range of change across DMPs # | Mean change | Range of change across DMPs # | |
PACIC (1; 5 highest = best) | 2.80 (0.84) | 0.10** (0.80) | +0.02; +0.26 | 2.92 (0.89) | −0.03 (0.75) | −0.05; +0.06 | 3.29 (0.85) | −0.23* * (0.72) | −0.27; − 0.18 | 0.01 (0.78) | −0.27; +0.26 |
Physically active days per week | 5.00 (2.07) | 0.33** (2.15) | −0.23; +0.82 | 4.82 (2.13) | 0.37** (2.20) | −0.11; +1.36 | 4.74 (1.94) | 0.29 (2.01) | +0.05; +0.89 | 0.34** (2.14) | −0.23; +1.36 |
% smokers | 21 | −6 pp** | −2.5 pp; −10.7 pp | 39 | −11 pp** | −7.3 pp;-13.7 pp | 22 | −9 pp** | −8 pp; −13.6 pp | −8 pp** | −13.7 pp; −2.5 pp |
Self-efficacy (1; 6 highest = best) | 4.45 (0.87) | −0.28** (0.75) | −0.33; − 0.15 | 4.33 (0.88) | −0.34** (0.73) | −0.48; −0.27 | 4.56 (0.85) | −0.29** (0.77) | −0.42; −0.22 | −0.30** (0.75) | −0.48; −0.15 |
EQ-5D (−0.33; 1 highest = best) | 0.83 (0.18) | −0.01* (0.16) | −0.06; +0.03 | 0.79 (0.20) | −0.04** (0.19) | −0.04; − 0.03 | 0.84 (0.16) | −0.03* (0.14) | −0.04; −0.02 | −0.02** (0.17) | −0.06; +0.03 |